000			01629 a2200469 4500
005			20250513221409.0
264		0	_c20010118
008			200101s 0 0 eng d
022			_a0277-0008
024	7		_a10.1592/phco.20.13.1051.35028 _2doi
040			_aNLM _beng _cNLM
100	1		_aTaylor, D M
245	0	0	_aThe psychometric and cardiac effects of dimenhydrinate in the hyperbaric environment. _h[electronic resource]
260			_bPharmacotherapy _cSep 2000
300			_a1051-4 p. _bdigital
500			_aPublication Type: Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
650	0	4	_aAged
650	0	4	_aAnalysis of Variance
650	0	4	_aAtmosphere Exposure Chambers
650	0	4	_aAtmospheric Pressure
650	0	4	_aCross-Over Studies
650	0	4	_aDimenhydrinate _xpharmacology
650	0	4	_aDiving _xphysiology
650	0	4	_aDouble-Blind Method
650	0	4	_aFemale
650	0	4	_aHeart Rate _xdrug effects
650	0	4	_aHistamine H1 Antagonists _xpharmacology
650	0	4	_aHumans
650	0	4	_aMale
650	0	4	_aMemory _xdrug effects
650	0	4	_aMental Processes _xdrug effects
650	0	4	_aMiddle Aged
650	0	4	_aPsychometrics
650	0	4	_aTrail Making Test _xstatistics & numerical data
650	0	4	_aVentricular Premature Complexes _xchemically induced
700	1		_aO'Toole, K S
700	1		_aAuble, T E
700	1		_aRyan, C M
700	1		_aSherman, D R
773	0		_tPharmacotherapy _gvol. 20 _gno. 9 _gp. 1051-4
856	4	0	_uhttps://doi.org/10.1592/phco.20.13.1051.35028 _zAvailable from publisher's website
999			_c10945697 _d10945697